Dana-Farber Cancer Institute - Hematology/Oncology

Boston, Massachusetts 02215

2 studies enrolling now · 5 studies all time

What they study most

AML, Chronic Myelogenous Leukemia, Classical Hodgkin's Lymphoma, Leukemia, MDS, Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Studies at this site

• A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — Recruiting now
• A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation — Recruiting now
• A Phase I Study of Oral Asciminib (ABL001) in Patients With CML or Ph+ ALL — Completed
• Phase II Study of Oral Panobinostat in Adult Participants With Relapsed/Refractory Classical Hodgkin's Lymphoma — Completed
• Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia — Completed